These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 23868898)

  • 1. Kidney disease and multiple myeloma.
    Heher EC; Rennke HG; Laubach JP; Richardson PG
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):2007-17. PubMed ID: 23868898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma light chain cast nephropathy, a review.
    Sathick IJ; Drosou ME; Leung N
    J Nephrol; 2019 Apr; 32(2):189-198. PubMed ID: 29730782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
    Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
    Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
    J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of acute kidney injury in symptomatic multiple myeloma.
    Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP;
    Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloma kidney: improving clinical outcomes?
    Haynes R; Leung N; Kyle R; Winearls CG
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):342-51. PubMed ID: 22920645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approach to diagnosis and management of acute renal failure in myeloma patients.
    Leung N; Behrens J
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):297-302. PubMed ID: 22920640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma.
    Hutchison CA; Batuman V; Behrens J; Bridoux F; Sirac C; Dispenzieri A; Herrera GA; Lachmann H; Sanders PW;
    Nat Rev Nephrol; 2011 Nov; 8(1):43-51. PubMed ID: 22045243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities.
    Davenport A; Merlini G
    Nephrol Dial Transplant; 2012 Oct; 27(10):3713-8. PubMed ID: 23114897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal improvement in myeloma with bortezomib plus plasma exchange.
    Burnette BL; Leung N; Rajkumar SV
    N Engl J Med; 2011 Jun; 364(24):2365-6. PubMed ID: 21675906
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal improvement in myeloma with plasma exchange.
    Hutchison C; Bridoux F; Fermand JP
    N Engl J Med; 2011 Sep; 365(11):1061; author reply 1062. PubMed ID: 21916654
    [No Abstract]   [Full Text] [Related]  

  • 12. Recovery of kidney function following delayed use of Theralite™ dialyzer in a patient with myeloma cast nephropathy.
    Dahal K; Shastri S; Narayanasami U; Bijol V; Rider K; Strom JA; Jaber BL
    Clin Nephrol; 2013 Apr; 79(4):318-22. PubMed ID: 22541683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute kidney injury with cast nephropathy.
    Walther C; Podoll AS; Finkel KW
    Clin Nephrol; 2014 Jul; 82(1):1-6. PubMed ID: 24725380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of acute renal failure: new aspects.
    Bock HA
    Contrib Nephrol; 1998; 124():43-55; discussion 55-63. PubMed ID: 10075513
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal improvement in myeloma with plasma exchange.
    Haspel RL; Cserti-Gazdewich C; Dzik WH
    N Engl J Med; 2011 Sep; 365(11):1061-2; author reply 1062. PubMed ID: 21916653
    [No Abstract]   [Full Text] [Related]  

  • 16. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P; Cook M
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.
    Mehta S; Shtaynberg N; Goldman M; Asti D; Kiroycheva M; Pepe J
    Hematology; 2012 Jul; 17(4):229-31. PubMed ID: 22889516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management options for cast nephropathy in multiple myeloma.
    Cockwell P; Hutchison CA
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchange in rapidly progressive renal failure due to multiple myeloma. A retrospective case series.
    Moist L; Nesrallah G; Kortas C; Espirtu E; Ostbye T; Clark WF
    Am J Nephrol; 1999; 19(1):45-50. PubMed ID: 10085449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable kidney recovery by extracorporeal light chain removal and anti-myeloma treatments in patients with newly diagnosed multiple myeloma and acute renal failure.
    Silvestrini G; Tatangelo P; Scaramucci L; Sfara G; Bondanini F; Niscola P; de Fabritiis P; Palumbo R
    Saudi J Kidney Dis Transpl; 2020; 31(6):1445-1447. PubMed ID: 33565464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.